SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-043704
Filing Date
2024-04-11
Accepted
2024-04-11 16:10:48
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-11

Document Format Files

Seq Description Document Type Size
1 ARS annual_report.pdf ARS 2355668
  Complete submission text file 0000950170-24-043704.txt   3246223
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38541 | Film No.: 24838629
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)